| Year |
Citation |
Score |
| 2017 |
Freire RC, Amrein R, Mochcovitch MD, Dias GP, Machado S, Versiani M, Arias-Carrión O, Carta MG, Nardi AE. A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine. Journal of Clinical Psychopharmacology. PMID 28609307 DOI: 10.1097/Jcp.0000000000000740 |
0.457 |
|
| 2013 |
Fontenelle JM, Harrison BJ, Santana L, Conceição do Rosário M, Versiani M, Fontenelle LF. Correlates of insight into different symptom dimensions in obsessive-compulsive disorder. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 25: 11-6. PMID 23376865 |
0.556 |
|
| 2012 |
Costa RT, Cheniaux E, Rangé BP, Versiani M, Nardi AE. Group cognitive behavior therapy for bipolar disorder can improve the quality of life. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De BiofãSica ... [Et Al.]. 45: 862-8. PMID 22735175 DOI: 10.1590/S0100-879X2012007500109 |
0.414 |
|
| 2012 |
Fountoulakis KN, Kasper S, Andreassen O, Blier P, Okasha A, Severus E, Versiani M, Tandon R, Möller HJ, Vieta E. Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 262: 1-48. PMID 22622948 DOI: 10.1007/S00406-012-0323-X |
0.416 |
|
| 2012 |
Nardi AE, Freire RC, Mochcovitch MD, Amrein R, Levitan MN, King AL, Valença AM, Veras AB, Paes F, Sardinha A, Nascimento I, de-Melo-Neto VL, Dias GP, E Silva AC, Soares-Filho GL, ... ... Versiani M, et al. A randomized, naturalistic, parallel-group study for the long-term treatment of panic disorder with clonazepam or paroxetine. Journal of Clinical Psychopharmacology. 32: 120-6. PMID 22198456 DOI: 10.1097/Jcp.0B013E31823Fe4Bd |
0.403 |
|
| 2012 |
Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein DJ, Versiani M, Möller HJ. Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders. European Archives of Psychiatry and Clinical Neuroscience. 262: 13-22. PMID 22083391 DOI: 10.1007/S00406-011-0274-7 |
0.448 |
|
| 2011 |
Baghai TC, Blier P, Baldwin DS, Bauer M, Goodwin GM, Fountoulakis KN, Kasper S, Leonard BE, Malt UF, Stein D, Versiani M, Möller HJ. General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience. 261: 207-45. PMID 22033583 DOI: 10.1007/S00406-011-0259-6 |
0.446 |
|
| 2011 |
Costa RT, Cheniaux E, Rosaes PA, Carvalho MR, Freire RC, Versiani M, Rangé BP, Nardi AE. The effectiveness of cognitive behavioral group therapy in treating bipolar disorder: a randomized controlled study. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 33: 144-9. PMID 21829907 DOI: 10.1590/S1516-44462011000200009 |
0.459 |
|
| 2011 |
Nardi AE, Valença AM, Freire RC, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O e Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, Mezzasalma MA, ... ... Versiani M, et al. Randomized, open naturalistic, acute treatment of panic disorder with clonazepam or paroxetine. Journal of Clinical Psychopharmacology. 31: 259-61. PMID 21364347 DOI: 10.1097/Jcp.0B013E318210B4Ee |
0.466 |
|
| 2011 |
Nardi AE, Valença AM, Freire RC, Mochcovitch MD, Amrein R, Sardinha A, Levitan MN, Nascimento I, de-Melo-Neto VL, King AL, de O E Silva AC, Veras AB, Dias GP, Soares-Filho GL, da Costa RT, ... ... Versiani M, et al. Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Mã©Dicas E Biolã³Gicas / Sociedade Brasileira De BiofãSica ... [Et Al.]. 44: 366-73. PMID 21344132 DOI: 10.1590/S0100-879X2011007500020 |
0.511 |
|
| 2011 |
de Menezes GB, Coutinho ES, Fontenelle LF, Vigne P, Figueira I, Versiani M. Second-generation antidepressants in social anxiety disorder: meta-analysis of controlled clinical trials. Psychopharmacology. 215: 1-11. PMID 21181129 DOI: 10.1007/S00213-010-2113-3 |
0.591 |
|
| 2011 |
Versiani M, Cheniaux E, Landeira-Fernandez J. Efficacy and safety of electroconvulsive therapy in the treatment of bipolar disorder: a systematic review. The Journal of Ect. 27: 153-64. PMID 20562714 DOI: 10.1097/Yct.0B013E3181E6332E |
0.46 |
|
| 2011 |
Nardi AE, Mochcovitch MD, Freire RC, Amrein R, Versiani M. P.4.a.001 Treatment of the acute phase of panic disorder: an eight-week randomised, naturalistic trial with clonazepam and paroxetine European Neuropsychopharmacology. 21. DOI: 10.1016/S0924-977X(11)70855-0 |
0.414 |
|
| 2010 |
Fontenelle IS, Fontenelle LF, Borges MC, Prazeres AM, Rangé BP, Mendlowicz MV, Versiani M. Quality of life and symptom dimensions of patients with obsessive-compulsive disorder. Psychiatry Research. 179: 198-203. PMID 20483484 DOI: 10.1016/J.Psychres.2009.04.005 |
0.608 |
|
| 2010 |
Nardi AE, Freire RC, Valença AM, Amrein R, de Cerqueira AC, Lopes FL, Nascimento I, Mezzasalma MA, Veras AB, Sardinha A, de Carvalho MR, da Costa RT, Levitan MN, de-Melo-Neto VL, Soares-Filho GL, ... Versiani M, et al. Tapering clonazepam in patients with panic disorder after at least 3 years of treatment. Journal of Clinical Psychopharmacology. 30: 290-3. PMID 20473065 DOI: 10.1097/Jcp.0B013E3181Dcb2F3 |
0.383 |
|
| 2010 |
Fontenelle IS, Prazeres AM, Borges MC, Rangé BP, Versiani M, Fontenelle LF. The Brazilian Portuguese version of the Saving Inventory-Revised: internal consistency, test-retest reliability, and validity of a questionnaire to assess hoarding. Psychological Reports. 106: 279-96. PMID 20402454 DOI: 10.2466/Pr0.106.1.279-296 |
0.603 |
|
| 2010 |
Santana L, Versiani M, Mendlowicz MV, Fontenelle LF. Predictors of adherence among patients with obsessive-compulsive disorder undergoing naturalistic pharmacotherapy. Journal of Clinical Psychopharmacology. 30: 86-8. PMID 20075661 DOI: 10.1097/Jcp.0B013E3181C8272A |
0.646 |
|
| 2010 |
Nardi AE, Lopes FL, Valença AM, Freire RC, Nascimento I, Veras AB, Mezzasalma MA, de-Melo-Neto VL, Soares-Filho GL, King AL, Grivet LO, Rassi A, Versiani M. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder. Psychiatry Research. 175: 260-5. PMID 20036427 DOI: 10.1016/J.Psychres.2008.06.025 |
0.467 |
|
| 2010 |
Davidson JR, Zhang W, Connor KM, Ji J, Jobson K, Lecrubier Y, McFarlane AC, Newport DJ, Nutt DJ, Osser DN, Stein DJ, Stowe ZN, Tajima O, Versiani M. A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). Journal of Psychopharmacology (Oxford, England). 24: 3-26. PMID 18832431 DOI: 10.1177/0269881108096505 |
0.357 |
|
| 2010 |
Novis F, Cheniaux E, Landeira-Fernandez J, Versiani M. A five year follow-up study of 11 patients with bipolar disorder Jornal Brasileiro De Psiquiatria. 59: 219-222. DOI: 10.1590/S0047-20852010000300008 |
0.44 |
|
| 2009 |
Cheniaux E, Landeira-Fernandez J, Versiani M. The diagnoses of schizophrenia, schizoaffective disorder, bipolar disorder and unipolar depression: interrater reliability and congruence between DSM-IV and ICD-10. Psychopathology. 42: 293-8. PMID 19609099 DOI: 10.1159/000228838 |
0.446 |
|
| 2009 |
Keck PE, Versiani M, Warrington L, Loebel AD, Horne RL. Long-term safety and efficacy of ziprasidone in subpopulations of patients with bipolar mania. The Journal of Clinical Psychiatry. 70: 844-51. PMID 19573482 DOI: 10.4088/Jcp.08M04045 |
0.371 |
|
| 2009 |
Fontenelle LF, Mendlowicz MV, Versiani M. Volitional disorders: a proposal for DSM-V. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 10: 1016-29. PMID 18609413 DOI: 10.1080/15622970701858771 |
0.623 |
|
| 2009 |
Mululo SCC, De Menezes GB, Fontenelle L, Versiani M. Effectiveness of cognitive and/or behavioral therapy for social anxiety disorder | Eficácia do tratamento cognitivo e/ou comportamental para o transtorno de ansiedade social Revista De Psiquiatria Do Rio Grande Do Sul. 31: 177-186. DOI: 10.1590/S0101-81082009000300007 |
0.557 |
|
| 2009 |
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 2a parte: Tratamento de manutenção do transtorno depressivo maior e tratamento dos transtornos depressivos crônicos e das depressões subliminares Revista De Psiquiatria Clinica. 36: 58-76. DOI: 10.1590/S0101-60832009000800002 |
0.31 |
|
| 2009 |
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ, Allain H, Anderson I, Ayuso-Gutierrez JL, Baldwin D, Bech P, Benkert O, Berk M, Bitter I, Bourgeois ML, Burrows G, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, part 1: Acute and continuation treatment of major depressive disorder | Diretrizes da World Federation of Societies of Biological Psychiatry (WFSBP) para tratamento biológico de transtornos depressivos unipolares, 1a parte: Tratamento agudo e de continuação do transtorno depressivo maior Revista De Psiquiatria Clinica. 36: 17-57. DOI: 10.1590/S0101-60832009000800001 |
0.434 |
|
| 2009 |
Mululo SCC, Menezes GBd, Fontenelle L, versiani M. Terapias cognitivo-comportamentais, terapias cognitivas e técnicas comportamentais para o transtorno de ansiedade social Archives of Clinical Psychiatry (SãO Paulo). 36: 221-228. DOI: 10.1590/S0101-60832009000600002 |
0.463 |
|
| 2009 |
de-Melo-Neto VL, King ALS, Valença AM, Freire RCdR, Nardi AE, Versiani M. Respiratory and non-respiratory panic disorder subtypes: clinical and quality of life comparisons. Revista Portuguesa De Pneumologia. 15: 859-874. DOI: 10.1016/S2173-5115(09)70158-7 |
0.411 |
|
| 2009 |
Nardi A, Valença A, Freire R, Lopes F, Nascimento I, King A, Sardinha A, Levitan M, de Carvalho M, de-Melo-Neto V, Mezzasalma M, Soares-Filho G, de Cerqueira A, da Costa R, Versiani M. FC05-01 A randomized naturalistic open long-term treatment of panic disorder with clonazepam or paroxetine European Psychiatry. 24: S313. DOI: 10.1016/S0924-9338(09)70546-2 |
0.388 |
|
| 2008 |
Bezerra De Menezes G, Fontenelle LF, Versiani M. Gender effect on clinical features and drug treatment response in social anxiety disorder (social phobia). International Journal of Psychiatry in Clinical Practice. 12: 151-5. PMID 24916628 DOI: 10.1080/13651500701568317 |
0.605 |
|
| 2008 |
Fontenelle LF, Lopes AP, Borges MC, Pacheco PG, Nascimento AL, Versiani M. Auditory, visual, tactile, olfactory, and bodily hallucinations in patients with obsessive-compulsive disorder. Cns Spectrums. 13: 125-30. PMID 18227743 DOI: 10.1017/S1092852900016278 |
0.638 |
|
| 2008 |
Cheniaux E, Landeira-Fernandez J, Lessa Telles L, Lessa JL, Dias A, Duncan T, Versiani M. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. Journal of Affective Disorders. 106: 209-17. PMID 17719092 DOI: 10.1016/J.Jad.2007.07.009 |
0.502 |
|
| 2008 |
Nardi AE, Nascimento I, Freire RC, Veras AB, de-Melo-Neto VL, Valença AM, Lopes FL, Soares-Filho GL, Levitan MN, de Carvalho MR, da Costa RT, King AL, Mezzasalma MA, Grivet LO, Rassi A, ... Versiani M, et al. Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective study. Journal of Affective Disorders. 106: 185-9. PMID 17604118 DOI: 10.1016/J.Jad.2007.05.026 |
0.494 |
|
| 2007 |
Menezes GB, Fontenelle LF, Mululo S, Versiani M. [Treatment-resistant anxiety disorders: social phobia, generalized anxiety disorder and panic disorder]. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 29: S55-60. PMID 18157434 DOI: 10.1590/S1516-44462007000600004 |
0.651 |
|
| 2007 |
Menezes GB, Fontenelle LF, Versiani M. [Reply to Dr. Crippa's letter "Are there differences between early- and late-onset social anxiety disorder?". ]. Revista Brasileira De Psiquiatria (SãO Paulo, Brazil : 1999). 29: 196-7. PMID 17639267 DOI: 10.1590/S1516-44462007000200028 |
0.606 |
|
| 2007 |
Fontenelle LF, de Souza WF, de Menezes GB, Mendlowicz MV, Miotto RR, Falcão R, Versiani M, Figueira IL. Sexual function and dysfunction in Brazilian patients with obsessive-compulsive disorder and social anxiety disorder. The Journal of Nervous and Mental Disease. 195: 254-7. PMID 17468686 DOI: 10.1097/01.Nmd.0000243823.94086.6F |
0.582 |
|
| 2007 |
Bauer M, Bschor T, Pfennig A, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 8: 67-104. PMID 17455102 DOI: 10.1080/15622970701227829 |
0.434 |
|
| 2007 |
Fontenelle LF, Domingues AM, Souza WF, Mendlowicz MV, de Menezes GB, Figueira IL, Versiani M. History of trauma and dissociative symptoms among patients with obsessive-compulsive disorder and social anxiety disorder. The Psychiatric Quarterly. 78: 241-50. PMID 17453345 DOI: 10.1007/S11126-007-9043-1 |
0.659 |
|
| 2007 |
Fontenelle LF, Nascimento AL, Mendlowicz MV, Shavitt RG, Versiani M. An update on the pharmacological treatment of obsessive-compulsive disorder. Expert Opinion On Pharmacotherapy. 8: 563-83. PMID 17376013 DOI: 10.1517/14656566.8.5.563 |
0.591 |
|
| 2007 |
Fontenelle LF, Lauterbach EC, Telles LL, Versiani M, Porto FH, Mendlowicz MV. Catatonia in obsessive-compulsive disorder: etiopathogenesis, differential diagnosis, and clinical management. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 20: 21-4. PMID 17356340 DOI: 10.1097/Wnn.0B013E31802E3Bc6 |
0.645 |
|
| 2007 |
Fontenelle LF, Mendlowicz MV, Versiani M. São as compulsões de checagem e lavagem marcadores válidos de diferentes subtipos do TOC? Revista Brasileira De Psiquiatria. 29: 297-297. DOI: 10.1590/S1516-44462007000300024 |
0.44 |
|
| 2007 |
Del Porto JA, De Mello AF, Kerr-Correa F, Dos Santos A, Moreno RA, Dos Santos CHR, Chaves AV, Versiani M, Nardi AE, De Oliveira IR, Ribeiro MG, Kapczinski F, Gazalle F, Frey B, Tamai S. Fluvoxamine in the treatment of major depressive disorder: An open multicentric study | Fluvoxamina no transtorno depressivo maior: Um estudo multicêntrico aberto Jornal Brasileiro De Psiquiatria. 56: 17-22. DOI: 10.1590/S0047-20852007000100006 |
0.421 |
|
| 2007 |
Fontenelle LF, Mendlowicz MV, Versiani M. Are checking and washing compulsions valid markers of different subtypes of OCD? [7] | São as compulsões de checagem e lavagem marcadores válidos de diferentes subtipos do TOC? Revista Brasileira De Psiquiatria. 29: 297. |
0.456 |
|
| 2007 |
De Menezes GB, Fontenelle LF, Versiani M. Reply to Dr. Crippa's letter "are there differences between early- and late-onset social anxiety disorder?" [10] Revista Brasileira De Psiquiatria. 29: 196-197. |
0.561 |
|
| 2006 |
Fontenelle LF, Telles LL, Nazar BP, de Menezes GB, do Nascimento AL, Mendlowicz MV, Versiani M. A sociodemographic, phenomenological, and long-term follow-up study of patients with body dysmorphic disorder in Brazil. International Journal of Psychiatry in Medicine. 36: 243-59. PMID 17154152 DOI: 10.2190/B6Xm-Hlhq-7X6C-8Gc0 |
0.585 |
|
| 2006 |
Versiani M. Ziprasidone in bipolar disorder. Expert Opinion On Pharmacotherapy. 7: 1221-8. PMID 16732708 DOI: 10.1517/14656566.7.9.1221 |
0.41 |
|
| 2006 |
Fontenelle LF, Mendlowicz MV, Kalaf J, Versiani M. The problem of delusional ugliness: is it really body dysmorphic disorder? The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 7: 110-5. PMID 16684683 DOI: 10.1080/15622970500287420 |
0.629 |
|
| 2006 |
Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 30: 327-37. PMID 16412548 DOI: 10.1016/J.Pnpbp.2005.11.001 |
0.607 |
|
| 2006 |
Fontenelle LF, Mendlowicz MV, Ribeiro P, Piedade RA, Versiani M. Low-resolution electromagnetic tomography and treatment response in obsessive-compulsive disorder. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 9: 89-94. PMID 15941492 DOI: 10.1017/S1461145705005584 |
0.579 |
|
| 2006 |
Fontenelle LF, Mendlowicz MV, Mattos P, Versiani M. Neuropsychological findings in obsessive-compulsive disorder and its potential implications for treatment Current Psychiatry Reviews. 2: 11-26. DOI: 10.2174/157340006775101454 |
0.575 |
|
| 2006 |
De Menezes GB, Fontenelle LF, Versiani M. Trans-cultural aspects of social anxiety disorder and related conditions: A Brazilian case series and a review of international clinical studies Jornal Brasileiro De Psiquiatria. 55: 196-200. DOI: 10.1590/S0047-20852006000300004 |
0.632 |
|
| 2005 |
Nardi AE, Valença AM, Nascimento I, Lopes FL, Mezzasalma MA, Freire RC, Veras AB, Zin WA, Versiani M. A three-year follow-up study of patients with the respiratory subtype of panic disorder after treatment with clonazepam. Psychiatry Research. 137: 61-70. PMID 16226812 DOI: 10.1016/J.Psychres.2005.05.011 |
0.447 |
|
| 2005 |
Fontenelle LF, Mendlowicz MV, Versiani M. Clinical subtypes of obsessive-compulsive disorder based on the presence of checking and washing compulsions. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 27: 201-7. PMID 16224607 DOI: 10.1590/S1516-44462005000300008 |
0.655 |
|
| 2005 |
Nardi AE, Nascimento I, Freire RC, de-Melo-Neto VL, Valença AM, Dib M, Soares-Filho GL, Veras AB, Mezzasalma MA, Lopes FL, de Menezes GB, Grivet LO, Versiani M. Demographic and clinical features of schizoaffective (schizobipolar) disorder--a 5-year retrospective study. Support for a bipolar spectrum disorder. Journal of Affective Disorders. 89: 201-6. PMID 16202454 DOI: 10.1016/J.Jad.2005.08.009 |
0.521 |
|
| 2005 |
Fontenelle LF, Mendlowicz MV, Kalaf J, Domingues AM, Versiani M. Obsessions with aggressive content emerging during the course of panic disorder: a different subtype of obsessive-compulsive disorder? International Clinical Psychopharmacology. 20: 343-6. PMID 16192846 DOI: 10.1097/00004850-200511000-00012 |
0.668 |
|
| 2005 |
Fontenelle LF, Mendlowicz MV, Miguel EC, Versiani M. Citalopram plus reboxetine in treatment-resistant obsessive-compulsive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 6: 57-9. PMID 16097406 DOI: 10.1080/15622970510029740 |
0.602 |
|
| 2005 |
Menezes GB, Fontenelle LF, Versiani M. Early-onset social anxiety disorder in adults: clinical and therapeutic features. Revista Brasileira De Psiquiatria (Sã£O Paulo, Brazil : 1999). 27: 32-6. PMID 15867981 DOI: 10.1590/S1516-44462005000100009 |
0.654 |
|
| 2005 |
Valença AM, Nardi AE, Nascimento I, Lopes FL, Freire RC, Mezzasalma MA, Veras AB, Versiani M. Do social anxiety disorder patients belong to a bipolar spectrum subgroup? Journal of Affective Disorders. 86: 11-8. PMID 15820266 DOI: 10.1016/J.Jad.2004.12.007 |
0.519 |
|
| 2005 |
Versiani M, Moreno R, Ramakers-van Moorsel CJ, Schutte AJ. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. Cns Drugs. 19: 137-46. PMID 15697327 DOI: 10.2165/00023210-200519020-00004 |
0.38 |
|
| 2005 |
Fontenelle LF, Mendlowicz MV, Versiani M. Impulse control disorders in patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences. 59: 30-7. PMID 15679537 DOI: 10.1111/J.1440-1819.2005.01328.X |
0.681 |
|
| 2004 |
Fontenelle LF, Mendlowicz MV, Versiani M. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. Psychological Medicine. 34: 1367-8; author reply. PMID 15697063 |
0.552 |
|
| 2004 |
Fontenelle LF, do Rosário-Campos MC, Mendlowicz MV, Ferrão YA, Versiani M, Miguel EC. Treatment-response by age at onset in obsessive-compulsive disorder. Journal of Affective Disorders. 83: 283-4. PMID 15555726 DOI: 10.1016/J.Jad.2004.07.007 |
0.607 |
|
| 2004 |
Fontenelle LF, Mendlowicz MV, Soares ID, Versiani M. Patients with obsessive-compulsive disorder and hoarding symptoms: a distinctive clinical subtype? Comprehensive Psychiatry. 45: 375-83. PMID 15332201 DOI: 10.1016/J.Comppsych.2004.03.005 |
0.64 |
|
| 2004 |
Valença AM, Nardi AE, Mezzasalma MA, Nascimento I, Lopes FL, Zin WA, Versiani M. Clonidine in respiratory panic disorder subtype. Arquivos De Neuro-Psiquiatria. 62: 396-8. PMID 15273833 DOI: 10.1590/S0004-282X2004000300004 |
0.427 |
|
| 2004 |
Fontenelle LF, Mendlowicz MV, Marques C, Versiani M. Trans-cultural aspects of obsessive-compulsive disorder: a description of a Brazilian sample and a systematic review of international clinical studies. Journal of Psychiatric Research. 38: 403-11. PMID 15203292 DOI: 10.1016/J.Jpsychires.2003.12.004 |
0.619 |
|
| 2004 |
Fontenelle LF, Mendlowicz MV, Bezerra de Menezes G, dos Santos Martins RR, Versiani M. Asperger Syndrome, obsessive-compulsive disorder, and major depression in a patient with 45,X/46,XY mosaicism. Psychopathology. 37: 105-9. PMID 15153741 DOI: 10.1159/000078608 |
0.577 |
|
| 2004 |
Fontenelle LF, Mendlowicz MV, Versiani M. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit. Psychological Medicine. 34: 181; author reply 18. PMID 14971639 DOI: 10.1017/S003329170300103X |
0.598 |
|
| 2004 |
Mueser KT, Fontenelle LF, Mendlowicz MV, Versiani M, Nielen MMA, Den Boer JA. Correspondence (multiple letters) Psychological Medicine. 34: 1365-1369. DOI: 10.1017/S0033291704213848 |
0.355 |
|
| 2004 |
Kalaf J, Fontenelle LF, Mendlowicz MV, Miotto RR, Versiani M. Obsession or delusion? A phenomenological description of a patient with body dysmorphic disorder | Obsessâo on delirio? Descriçâo fenomenológica de uma paciente com transtorno dismórfico corporal Jornal Brasileiro De Psiquiatria. 53: 281-285. |
0.58 |
|
| 2003 |
Nardi AE, Nascimento I, Valença AM, Lopes FL, Mezzasalma MA, Zin WA, Versiani M. Respiratory panic disorder subtype: acute and long-term response to nortriptyline, a noradrenergic tricyclic antidepressant. Psychiatry Research. 120: 283-93. PMID 14561440 DOI: 10.1016/S0165-1781(03)00132-X |
0.471 |
|
| 2003 |
Valença AM, Nardi AE, Mezzasalma MA, Nascimento I, Zin WA, Lopes FL, Versiani M. Therapeutic response to benzodiazepine in panic disorder subtypes. Sã£O Paulo Medical Journal = Revista Paulista De Medicina. 121: 77-80. PMID 12870055 DOI: 10.1590/S1516-31802003000200009 |
0.557 |
|
| 2003 |
Fontenelle LF, Mendlowicz MV, Marques C, Versiani M. Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study. Journal of Psychiatric Research. 37: 127-33. PMID 12842166 DOI: 10.1016/S0022-3956(02)00087-0 |
0.664 |
|
| 2003 |
Kinrys G, Pollack MH, Simon NM, Worthington JJ, Nardi AE, Versiani M. Valproic acid for the treatment of social anxiety disorder. International Clinical Psychopharmacology. 18: 169-72. PMID 12702897 DOI: 10.1097/01.Yic.0000064261.66765.9F |
0.442 |
|
| 2003 |
Fontenelle LF, Mendlowicz MV, Marques C, Mattos P, Versiani M. Persistent neuropsychological deficits in the Kleine-Levin syndrome. Acta Neurologica Scandinavica. 107: 304-5; author reply . PMID 12675707 DOI: 10.1034/J.1600-0404.2003.00090.X |
0.479 |
|
| 2003 |
Keck PE, Versiani M, Potkin S, West SA, Giller E, Ice K. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial. The American Journal of Psychiatry. 160: 741-8. PMID 12668364 DOI: 10.1176/Appi.Ajp.160.4.741 |
0.484 |
|
| 2002 |
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 5-43. PMID 12479086 DOI: 10.3109/15622970209150599 |
0.434 |
|
| 2002 |
Bauer M, Whybrow PC, Angst J, Versiani M, Möller HJ. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 3: 69-86. PMID 12479080 DOI: 10.1590/S0101-60832009000800002 |
0.447 |
|
| 2002 |
Stein DJ, Versiani M, Hair T, Kumar R. Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study. Archives of General Psychiatry. 59: 1111-8. PMID 12470127 DOI: 10.1001/Archpsyc.59.12.1111 |
0.494 |
|
| 2002 |
Valença AM, Nardi AE, Nascimento I, Zin WA, Lopes FL, Mezzasalma MA, Versiani M. Early carbon dioxide challenge test may predict clinical response in panic disorder. Psychiatry Research. 112: 269-72. PMID 12450637 DOI: 10.1016/S0165-1781(02)00222-6 |
0.379 |
|
| 2002 |
Fontenelle LF, Mendlowicz MV, Mussi TC, Marques C, Versiani M. The man with the purple nostrils: a case of rhinotrichotillomania secondary to body dysmorphic disorder. Acta Psychiatrica Scandinavica. 106: 464-6; discussion 46. PMID 12392491 DOI: 10.1034/J.1600-0447.2002.01463.X |
0.572 |
|
| 2002 |
Nardi AE, Nascimento I, Valença AM, Lopes FL, Zin WA, Mezzasalma MA, Versiani M. A breath-holding challenge in panic disorder patients, their healthy first-degree relatives, and normal controls. Respiratory Physiology & Neurobiology. 133: 43-7. PMID 12385730 DOI: 10.1016/S1569-9048(02)00149-0 |
0.383 |
|
| 2002 |
Hirschfeld RM, Montgomery SA, Aguglia E, Amore M, Delgado PL, Gastpar M, Hawley C, Kasper S, Linden M, Massana J, Mendlewicz J, Möller HJ, Nemeroff CB, Saiz J, Such P, ... ... Versiani M, et al. Partial response and nonresponse to antidepressant therapy: current approaches and treatment options. The Journal of Clinical Psychiatry. 63: 826-37. PMID 12363125 DOI: 10.4088/Jcp.V63N0913 |
0.357 |
|
| 2002 |
Fontenelle LF, Mendlowicz MV, de Menezes GB, Appolinário JC, Marques C, Coutinho W, Godoy-Matos A, Versiani M. Comparison of symptom profiles of obese binge eaters, obese non-binge eaters, and patients with obsessive-compulsive disorder. The Journal of Nervous and Mental Disease. 190: 643-6. PMID 12357101 DOI: 10.1097/00005053-200209000-00013 |
0.541 |
|
| 2002 |
Nardi AE, Valença AM, Nascimento I, Zin WA, Versiani M. Carbon dioxide test in respiratory panic disorder subtype. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 47: 685-6. PMID 12355684 DOI: 10.1177/070674370204700719 |
0.377 |
|
| 2002 |
Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, Nelson J, Paykel E, Versiani M, Racagni G. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 12: 461-75. PMID 12208564 DOI: 10.1016/S0924-977X(02)00057-3 |
0.334 |
|
| 2002 |
Andreoli V, Caillard V, Deo RS, Rybakowski JK, Versiani M. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression. Journal of Clinical Psychopharmacology. 22: 393-9. PMID 12172339 DOI: 10.1097/00004714-200208000-00010 |
0.355 |
|
| 2002 |
Valença AM, Nardi AE, Nascimento I, Zin WA, Versiani M. Carbon dioxide test as an additional clinical measure of treatment response in panic disorder. Arquivos De Neuro-Psiquiatria. 60: 358-61. PMID 12131931 DOI: 10.1590/S0004-282X2002000300003 |
0.342 |
|
| 2002 |
Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, Savino M. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. The Journal of Clinical Psychiatry. 63: 31-7. PMID 11838623 DOI: 10.4088/Jcp.V63N0107 |
0.519 |
|
| 2002 |
Fontenelle L, Marques C, Versiani M. The effect of gender on the clinical features and therapeutic response in obsessive-compulsive disorder Revista Brasileira De Psiquiatria. 24: 7-11. DOI: 10.1590/S1516-44462002000100005 |
0.639 |
|
| 2001 |
Fontenelle L, Marques C, Engelhardt E, Versiani M. Impaired set-shifting ability and therapeutic response in obsessive-compulsive disorder. The Journal of Neuropsychiatry and Clinical Neurosciences. 13: 508-10. PMID 11748320 DOI: 10.1176/Jnp.13.4.508 |
0.609 |
|
| 2000 |
Versiani M. Reboxetine, the first selective noradrenaline reuptake inhibitor antidepressant: Efficacy and tolerability in 2613 patients. International Journal of Psychiatry in Clinical Practice. 4: 201-8. PMID 24927454 DOI: 10.1080/13651500050518082 |
0.381 |
|
| 2000 |
Versiani M. The selective noradrenaline re-uptake inhibitor reboxetine has an early onset of antidepressant action. International Journal of Psychiatry in Clinical Practice. 4: 293-7. PMID 24926580 DOI: 10.1080/13651500050517858 |
0.346 |
|
| 2000 |
Versiani M. A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia). The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1: 27-33. PMID 12607230 DOI: 10.3109/15622970009150563 |
0.439 |
|
| 2000 |
Fontenelle L, Soares ID, Marques C, Rangé B, Mendlowicz MV, Versiani M. Sudden remission of obsessive-compulsive disorder by involuntary, massive exposure. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 45: 666-7. PMID 11056831 |
0.323 |
|
| 2000 |
Fontenelle L, Piedade RA, Marques C, de Menezes GB, Versiani M. [Quantitative electroencephalography in obsessive-compulsive disorder: preliminary results]. Arquivos De Neuro-Psiquiatria. 58: 677-82. PMID 10973109 DOI: 10.1590/S0004-282X2000000400013 |
0.494 |
|
| 2000 |
Fontenelle L, Mendlowicz MV, Gillin JC, Mattos P, Versiani M. Neuropsychological sequelae in Kleine-Levin syndrome: case report. Arquivos De Neuro-Psiquiatria. 58: 531-4. PMID 10920418 DOI: 10.1590/S0004-282X2000000300021 |
0.497 |
|
| 2000 |
Hirschfeld RM, Montgomery SA, Keller MB, Kasper S, Schatzberg AF, Möller HJ, Healy D, Baldwin D, Humble M, Versiani M, Montenegro R, Bourgeois M. Social functioning in depression: a review. The Journal of Clinical Psychiatry. 61: 268-75. PMID 10830147 DOI: 10.4088/Jcp.V61N0405 |
0.36 |
|
| 2000 |
Versiani M, Amin M, Chouinard G. Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder. Journal of Clinical Psychopharmacology. 20: 28-34. PMID 10653205 DOI: 10.1097/00004714-200002000-00006 |
0.436 |
|
| 2000 |
Versiani M. Reboxetine, a novel selective NRI, in the treatment of panic disorder European Neuropsychopharmacology. 10: 245-246. DOI: 10.1016/S0924-977X(00)80197-2 |
0.366 |
|
| 2000 |
Fontenelle L, Marques C, Engelhardt E, Versiani M. Soft neurological signs in eorly and lote-onsel obsessive-compulsive disorder: Pilot study | Sinais neurologicos menores no transtorno obsessivo compulsivo de inicios precoce e tardio: Estudo piloto Psiquiatria Biologica. 8: 41-47. |
0.363 |
|
| 1999 |
Versiani M, Mehilane L, Gaszner P, Arnaud-Castiglioni R. Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder. The Journal of Clinical Psychiatry. 60: 400-6. PMID 10401920 DOI: 10.4088/Jcp.V60N0610 |
0.395 |
|
| 1999 |
Versiani M, Mehilane L, Gaszner P, Arnaud-Castiglioni R. Reboxetine, a unique slective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder Primary Care Companion to the Journal of Clinical Psychiatry. 1: 126. |
0.303 |
|
| 1999 |
Versiani M, Nardi AE. Open label clinical trial with cloxazolam in the treatment of panic or generalized anxiety disorders | Ensaio clinico aberto como cloxazolam no tratamento do transtorno do panico ou do transtorno da ansiedade generalizada Revista Brasileira De Medicina. 56: 695-702. |
0.365 |
|
| 1999 |
Figueira I, Nardi AE, Marques C, Versiani M. Diagnosis and treatment of somatoform disorders | Diagnostico tratamento dos transtornos somatomorfos Jornal Brasileiro De Psiquiatria. 48: 35-42. |
0.354 |
|
| 1998 |
Versiani M, Nardi AE, Figueira I. Pharmacotherapy of dysthymia: review and new findings. European Psychiatry : the Journal of the Association of European Psychiatrists. 13: 203-9. PMID 19698626 DOI: 10.1016/S0924-9338(98)80005-9 |
0.333 |
|
| 1998 |
Versiani M. Pharmacotherapy of dysthymic and chronic depressive disorders: overview with focus on moclobemide. Journal of Affective Disorders. 51: 323-32. PMID 10333986 DOI: 10.1016/S0165-0327(98)00228-6 |
0.355 |
|
| 1998 |
Fontenelle L, Marques C, Figueira I, Nardi AE, Versiani M. The effect-size of clomipramine in obsessive-compulsive disorder | Tamanho do efeito da clomipramina no transtorno obsessivo-compulsivo Serie Psicofarmacologia - 71 Jornal Brasileiro De Psiquiatria. 47: 131-143. |
0.313 |
|
| 1997 |
Versiani M, Amrein R, Stabl M. Moclobemide and imipramine in chronic depression (dysthymia): an international double-blind, placebo-controlled trial. International Collaborative Study Group. International Clinical Psychopharmacology. 12: 183-93. PMID 9347378 DOI: 10.1097/00004850-199707000-00001 |
0.396 |
|
| 1996 |
Bandelow B, Amering M, Benkert O, Marks I, Nardi AE, Osterheider M, Tannock C, Tremper J, Versiani M. Cardio-respiratory and other symptom clusters in panic disorder. Anxiety. 2: 99-101. PMID 9160609 DOI: 10.1002/(Sici)1522-7154(1996)2:2<99::Aid-Anxi7>3.0.Co;2-8 |
0.393 |
|
| 1996 |
Versiani M, Nardi AE, Mundim FD, Pinto S, Saboya E, Kovacs R. The long-term treatment of social phobia with moclobemide. International Clinical Psychopharmacology. 11: 83-8. PMID 8923115 DOI: 10.1097/00004850-199606003-00014 |
0.426 |
|
| 1992 |
Versiani M, Nardi AE, Mundim FD, Alves AB, Liebowitz MR, Amrein R. Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine. The British Journal of Psychiatry : the Journal of Mental Science. 161: 353-60. PMID 1393304 DOI: 10.1192/Bjp.161.3.353 |
0.338 |
|
| 1990 |
Versiani M, Nardi AE, Mundim FD, Alves A, Schmid-Burgk W. Moclobemide, imipramine and placebo in the treatment of major depression. Acta Psychiatrica Scandinavica. Supplementum. 360: 57-8. PMID 2248073 DOI: 10.1111/J.1600-0447.1990.Tb05331.X |
0.331 |
|
| 1990 |
Versiani M, Nardi AE, Figueira IL, Stabl M. Tolerability of moclobemide, a new reversible inhibitor of monoamine oxidase-A, compared with other antidepressants and placebo. Acta Psychiatrica Scandinavica. Supplementum. 360: 24-8. PMID 2123366 DOI: 10.1111/J.1600-0447.1990.Tb05320.X |
0.344 |
|
| 1988 |
Versiani M, Mundim FD, Nardi AE, Liebowitz MR. Tranylcypromine in social phobia. Journal of Clinical Psychopharmacology. 8: 279-83. PMID 3209719 DOI: 10.1097/00004714-198808000-00008 |
0.356 |
|
| 1980 |
Versiani M, da Silva JA, Mundim FD. Loxapine versus thioridazine in the treatment of organic psychosis. The Journal of International Medical Research. 8: 22-30. PMID 7358200 DOI: 10.1177/030006058000800104 |
0.359 |
|
| Show low-probability matches. |